Haijun Zhong

机构：Shanghai Jiao Tong University, Shanghai Chest Hospital, Zhejiang Cancer Hospital, Institute of Process Engineering, Cancer Hospital of Chinese Academy of Medical Sciences, Children's Hospital of Fudan University, University of Chinese Academy of Sciences, Hangzhou Cancer Hospital, China National Petroleum Corporation (China) · ORCID：0000-0002-2488-1645

发表论文 109 篇 · 总被引 2884 次 · h-index 19

代表论文

• Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial (2024 · Nature Medicine · 被引 36)
• An agile layer-resolved SOFC stack model using physics-informed neural network (2023 · International Journal of Hydrogen Energy · 被引 19)
• A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice (2024 · The Oncologist · 被引 11)
• Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study (2023 · Cell Reports Medicine · 被引 6)
• Effect of BaH2 on the hydrogen storage properties of Mg(NH2)2-LiH (2025 · Journal of Alloys and Compounds · 被引 5)
• Unveiling promotion effects of Ce doping in La0.6Ca0.4Co0.2Fe0.8O3-δ as an efficient cathode for solid oxide fuel cells (2025 · Journal of Power Sources · 被引 4)